SCHEMBL6080869

SCHEMBL6080869

Cc1ccc(S(=O)(=O)Nc2ccc(CCNC(=O)c3cc4cc(O)ccc4cc3O)cc2)cc1.O=C(NCCc1ccc(NS(=O)(=O)c2cccc(C(F)(F)F)c2)cc1)c1cc2cc(O)ccc2cc1O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 5/20 0.55
MAPT P10636 4/20 0.55
TP53 P04637 3/20 0.55
KDM1A O60341 2/20 0.53
GSK3B P49841 2/20 0.50
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
LMNA P02545 1/20 0.48
XBP1 P17861 1/20 0.48
ALOX12 P18054 1/20 0.48
HTT P42858 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B2 P37059 1/20 0.47
RECQL P46063 1/20 0.46
FFAR1 O14842 1/20 0.46
CDK1 P06493 1/20 0.46
CCNB1 P14635 1/20 0.46
CCNA2 P20248 1/20 0.46
CDK2 P24941 1/20 0.46
CDK7 P50613 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1918049 0.94 MAPT (0.49) POLBMAPTTP53KDM1AKMT2A
SCHEMBL6080848 0.90 KDM1A (0.52) POLBMAPTTP53KDM1AGSK3B
SCHEMBL1917291 0.89 KDM1A (0.60) POLBMAPTTP53KDM1AGSK3B
SCHEMBL1918574 0.89 CA12 (0.49) POLBMAPTTP53KDM1AGSK3B
SCHEMBL6081150 0.83 TP53 (0.43) POLBMAPTTP53KMT2AMEN1
SCHEMBL6081213 0.83 MEN1 (0.48) POLBMAPTTP53KDM1AGSK3B
SCHEMBL1917801 0.83 GSK3B (0.53) POLBKDM1AGSK3BKMT2AMEN1
SCHEMBL6081433 0.82 KDM1A (0.51) MAPTKDM1AGSK3BKMT2AMEN1
SCHEMBL1918211 0.81 SYK (0.56) KDM1AGSK3BHTTCA12CA1
SCHEMBL1917491 0.79 ESRRG (0.48) MAPTGSK3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060154933-A1 Inhibitors of Cdc25 phosphatases SCRAS 2006-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060154933-A1 Inhibitors of Cdc25 phosphatases CDC25A, CDC25C, CDC25B POLB 1585/4885MAPT 4147/4885TP53 263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.